Ledger.Open graph →
SEC Form D · filed July 10, 2018

CARISMA Therapeutics Inc

Offering
$53.2M
Sold
$26.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Nicholas A. Nash · NA, U0DirectorStacey Y. Goodman · Newark, NJDirectorTrey Hilberg · San Francisco, CAExec · DirectorAlthea Stillman · Philadelphia, PADirectorDavid A. Kloske · Huntsville, ALDirectorDavid T. Moore · Huntsville, ALExec · DirectorDanny J. Windham · Huntsville, ALDirectorEran Nadav · Sandy Hook, CTDirectorJacob Gunterberg · Philadelphia, PADirectorRegina Hodits · Munich, 2MDirectorAlthea Stillman · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗